Related Experiment Videos

Current perspectives on Kawasaki disease

Monesha Gupta-Malhotra1, P Syamasundar Rao

  • 1University of Texas Houston Medical School & Memorial Hermann Children's Hospital, Houston, Texas, USA. Monesha.gupta@uth.tmc.edu

Insights

Kawasaki disease (KD) etiology is unknown, but recent research implicates coronavirus and genetics. Diagnosis has evolved with new criteria for incomplete KD, while treatment challenges remain for immunoglobulin-resistant cases.

Area of Science:

  • Pediatrics
  • Rheumatology
  • Infectious Diseases

Background:

  • Kawasaki disease (KD) etiology remains elusive, with recent focus on coronavirus infection and genetic factors.
  • Diagnostic criteria for KD have seen minor updates, including revised fever duration and new criteria for incomplete and atypical forms.
  • Long-term outcomes and treatment strategies for KD, particularly for immunoglobulin-resistant cases, are areas of ongoing investigation.

Purpose of the Study:

  • To review the current understanding of Kawasaki disease etiology and diagnostic criteria.
  • To discuss treatment approaches for Kawasaki disease, including challenges in immunoglobulin-resistant cases.
  • To highlight recent findings on long-term outcomes and potential risks like premature atherosclerosis.

Main Methods:

  • Literature review of recent research on Kawasaki disease etiology.
  • Analysis of updated diagnostic criteria, including echocardiography and laboratory findings.
  • Summary of treatment modalities and outcomes for typical and resistant KD cases.

Main Results:

  • Etiology of Kawasaki disease is still unknown, with emerging links to coronavirus and genetic polymorphisms.
  • Updated diagnostic criteria now include specific criteria for incomplete Kawasaki disease.
  • Long-term follow-up data reveal concerns about increased risk of premature atherosclerosis in childhood KD survivors with coronary abnormalities.

Conclusions:

  • Kawasaki disease diagnosis and management continue to evolve, with ongoing research into its causes.
  • Effective treatment strategies for immunoglobulin-resistant Kawasaki disease are crucial.
  • Long-term surveillance for cardiovascular complications in Kawasaki disease patients is essential.

Related Concept Videos

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...